Writing a Somatic Symptom Disorder Case Study That Actually Gets Used
A case study on somatic symptom disorder isn't much different from any other clinical write-up, except you have to be more careful about how you frame the psychological layer. The DSM-5 criteria are straightforward enough on paper, but the moment you try to pin them to a real patient file, things get messy. I've written three of these over the years, and the ones that survived peer review were the ones where I got specific about the timeline and the rule-outs. Start with a concrete presentation. Not "a 42-year-old female presented with pain." Give me the exact symptom cluster, the duration, and the workup that already happened. Most reviewers skip past the intro anyway, so bury your lede in details. I once had a case where the patient had been through four negative cardiac evaluations and two GI scopes before the doctor even considered SSD. That sequence matters. It shows why the diagnosis was hard-won, not just slapped on. The diagnostic criteria require one or more somatic symptoms that are distressing or disruptive, plus excessive thoughts, feelings, or behaviors related to those symptoms. That second piece is where most case studies fumble. You need to document the cognitive and behavioral component separately from the physical complaint. Excessive health-related anxiety, disproportionate time spent researching symptoms, repeated checking, physician shopping, reassurance-seeking patterns. These are observable. Write them down with dates if you can.
Here's the thing beginners miss: severity specifiers matter more than people think. Mild, moderate, and severe aren't just labels. They determine treatment pathways and insurance coding, which in turn affects what interventions actually get documented in your study. If your patient qualifies as severe because symptoms cause major impairment, say so explicitly with functional consequences — missed work days, social withdrawal, inability to perform ADLs. Without that, reviewers will question whether the diagnosis is even justified. I ran into a real problem with one case that almost tanked the whole thing. The patient had concurrent generalized anxiety disorder and what looked like illness anxiety disorder. The DSM-5 allows comorbid SSD with another mental disorder, but only if the somatic symptoms exceed what you'd expect from the anxiety alone. My initial draft had the reviewer flag this — they argued the somatic presentation could be fully explained by the GAD. I had to go back and restructure the entire case, pulling out specific somatic symptoms that were independent of the anxiety symptoms and documenting why they met the threshold for separate SSD classification. The workaround was creating a side-by-side symptom timeline showing when each cluster emerged and how they diverged. It added six pages but saved the paper. For the intervention section, don't just say CBT was used. Specify the modality, the number of sessions, the therapist's theoretical orientation, and the measured outcomes. I prefer PHQ-15 and SSD-12 scores tracked at baseline, midpoint, and follow-up. Anything less feels like speculation. A single randomized controlled trial showed that CBT for SSD produces a mean reduction of about 4.2 points on the SSD-12 at 12 weeks, compared to 1.1 points in treatment-as-usual. Quote real numbers when you can. Vague language like "significant improvement" gets filtered out by automated plagiarism and quality checks.
One counter-intuitive point: comorbid personality traits, particularly borderline and avoidant features, don't disqualify a case. In fact, they're clinically relevant. Several studies show that higher somatic attention combined with emotional dysregulation predicts poorer response to standard CBT protocols. If your case has those features, acknowledge them early rather than letting reviewers discover them later and question your diagnostic rigor. It actually strengthens the study by showing you understood the complexity. Downsides of this approach? The biggest one is that case studies on SSD suffer from publication bias toward treatment-responsive cases. Failures get filed away, which skews the literature. If your case didn't respond well to intervention, you still have value in documenting that, but the journal you submit to may not share that view. Second, the SSD-12 and PHQ-12/15 aren't validated for all populations. Self-report versions work reasonably well, but clinician-rated scales are less standardized. If you're using them, note the limitation outright. A final practical note on formatting your case study for submission. Most clinical journals want the case presented in a narrative format with subsections, not a bullet-point summary. Lead with the case presentation, move through the diagnostic assessment, then the intervention, then the discussion placing your case in context with existing literature. Keep the discussion section focused on what your case adds — a diagnostic dilemma, an unusual comorbidity pattern, a treatment response that contradicts the literature. Don't rewrite the review article.
Get the Full Details
If you're looking for reference material on case study structure, the DSM-5-TR appendix on case formulations has a template that maps directly onto SSD documentation requirements. It's free on the APA website. The ICD-11 equivalent is less detailed but useful if you're working in a jurisdiction that requires dual coding. Most of my cases end up with both F45.0 and 6B40 codes for insurance purposes.
